Verition Fund Management LLC Abb Vie Inc. Transaction History

Verition Fund Management LLC

$17.4 Billion
Q3 2024

A detailed history of Verition Fund Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Verition Fund Management LLC holds 32,900 shares of ABBV stock, worth $5.92 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

32,900

Previous 80,200 58.98%

Holding current value

$5.92 Million

Previous $13.8 Million 52.77%

% of portfolio

0.04%

Previous 0.08%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$163.84 - $199.33 $2.64 Million - $3.22 Million	-16,142 Reduced 82.32%	3,466 $684,000
Q2 2024 Aug 14, 2024	BUY	$154.79 - $180.76 $943,909 - $1.1 Million	6,098 Added 45.14%	19,608 $3.36 Million
Q1 2024 May 14, 2024	SELL	$159.82 - $182.1 $163,495 - $186,288	-1,023 Reduced 7.04%	13,510 $2.46 Million
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $293,500 - $330,551	2,133 Added 17.2%	14,533 $2.25 Million
Q3 2023 Nov 14, 2023	SELL	$133.59 - $154.65 $1.91 Million - $2.21 Million	-14,283 Reduced 53.53%	12,400 $1.85 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $3.54 Million - $4.4 Million	26,683 New	26,683 $3.6 Million
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $460,987 - $552,844	-3,333 Reduced 36.04%	5,915 $956,000
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $1.06 Million - $1.22 Million	7,921 Added 596.91%	9,248 $1.24 Million
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $6.55 Million - $8.32 Million	-47,573 Reduced 97.29%	1,327 $203,000
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $4.92 Million - $6.22 Million	45,791 Added 1472.85%	48,900 $6.62 Million
Q3 2021 Nov 15, 2021	SELL	$106.4 - $120.78 $250,784 - $284,678	-2,357 Reduced 43.12%	3,109 $335,000
Q2 2021 Aug 16, 2021	SELL	$105.21 - $117.21 $321,732 - $358,428	-3,058 Reduced 35.88%	5,466 $616,000
Q3 2020 Nov 16, 2020	BUY	$85.91 - $100.83 $279,379 - $327,899	3,252 Added 61.68%	8,524 $747,000
Q2 2020 Aug 14, 2020	SELL	$73.37 - $98.18 $15.4 Million - $20.6 Million	-209,728 Reduced 97.55%	5,272 $518,000
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $13.3 Million - $20.2 Million	206,069 Added 2307.35%	215,000 $16.4 Million
Q4 2019 Feb 14, 2020	SELL	$72.13 - $90.25 $1.49 Million - $1.87 Million	-20,697 Reduced 69.86%	8,931 $791,000
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $863,889 - $1.1 Million	13,149 Added 79.79%	29,628 $2.16 Million
Q1 2019 May 15, 2019	BUY	$77.14 - $90.79 $1.27 Million - $1.5 Million	16,479 New	16,479 $1.33 Million
Q4 2018 Feb 14, 2019	SELL	$77.85 - $96.01 $319,496 - $394,025	-4,104 Closed	0 $0
Q3 2018 Nov 15, 2018	SELL	$88.91 - $98.84 $490,961 - $545,794	-5,522 Reduced 57.37%	4,104 $388,000
Q2 2018 Aug 15, 2018	BUY	$89.78 - $106.23 $211,611 - $250,384	2,357 Added 32.43%	9,626 $892,000
Q1 2018 May 16, 2018	BUY	$92.01 - $123.21 $46,005 - $61,605	500 Added 7.39%	7,269 $688,000
Q4 2017 Feb 15, 2018	BUY	$89.56 - $98.21 $606,231 - $664,783	6,769	6,769 $655,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.

Account

Verition Fund Management LLC Abb Vie Inc. Transaction History